Octadecylamine

Octadecylamine

SCHEMBL323069

CCCCCCCCCCCCCCCCCCN.O=CO

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 8/20 0.68
TSHR P16473 2/20 0.68
EPHX1 P07099 2/20 0.68
MEN1 O00255 1/20 0.68
KMT2A Q03164 1/20 0.68
ALDH1A1 P00352 1/20 0.68
SLC6A5 Q9Y345 2/20 0.44
GNAI3 P08754 1/20 0.43
GNAO1 P09471 1/20 0.43
GNAI1 P63096 1/20 0.43
GABBR2 O75899 1/20 0.43
GABRR1 P24046 1/20 0.43
GABBR1 Q9UBS5 1/20 0.43
PAOX Q6QHF9 1/20 0.42
ADH1B P00325 1/20 0.42
ADH1C P00326 1/20 0.42
ADH1A P07327 1/20 0.42
ADH4 P08319 1/20 0.42
ADH7 P40394 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL28544584 1.00 DNM1 (0.68) DNM1TSHREPHX1MEN1KMT2A
Formic Acid SCHEMBL28538944 1.00 DNM1 (0.68) DNM1TSHREPHX1MEN1KMT2A
Formic Acid SCHEMBL28544340 1.00 DNM1 (0.68) DNM1TSHREPHX1MEN1KMT2A
Formic Acid SCHEMBL1489420 1.00 DNM1 (0.68) DNM1TSHREPHX1MEN1KMT2A
Hexadecylamine SCHEMBL1897516 1.00 DNM1 (0.68) DNM1TSHREPHX1MEN1KMT2A
Formic Acid SCHEMBL1489065 1.00 DNM1 (0.68) DNM1TSHREPHX1MEN1KMT2A
Formic Acid SCHEMBL11684976 1.00 DNM1 (0.68) DNM1TSHREPHX1MEN1KMT2A
Decylamine SCHEMBL29208196 1.00 DNM1 (0.68) DNM1TSHREPHX1MEN1KMT2A
Dodecylamine SCHEMBL5968270 1.00 DNM1 (0.68) DNM1TSHREPHX1MEN1KMT2A
Formic Acid SCHEMBL28112450 1.00 DNM1 (0.68) DNM1TSHREPHX1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 878 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024000083-A1 EFFICIENT FLOTATION REAGENT SUITABLE FOR DIRECT FLOTATION PRODUCTION OF POTASSIUM CHLORIDE 华东理工大学 2024-01-04 WO claimed
CN-115025883-A Efficient flotation reagent suitable for potassium chloride direct flotation production 华东理工大学 2022-09-09 CN claimed
CN-101333120-B Detonation inhibitor for ammonium nitrate HAIQUAN YIN 2012-07-04 CN claimed
CN-101333120-A Detonation inhibitor for ammonium nitrate HAIQUAN YIN (CN) 2008-12-31 CN claimed
US-20070256987-A1 Chemically-enhanced mechanical treatment of water AQUALON COMPANY 2007-11-08 US claimed
WO-2007075681-A1 CHEMICALLY-ENHANCED MECHANICAL TREATMENT OF WATER HERCULES INCORPORATED (US) 2007-07-05 WO claimed
CN-1522138-A Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same 欧莱雅股份有限公司 2004-08-18 CN claimed
CN-1499952-A Compositions comprising heteropolymers and methods of use thereof 欧莱雅股份有限公司 2004-05-26 CN claimed
EP-1392232-A2 COSMETIC COMPOSITIONS CONTAINING HETEROPOLYMERS AND OIL-SOLUBLE CATIONIC SURFACTANTS AND METHODS OF USING SAME l'Oreal SA (FR) 2004-03-03 EP claimed
EP-1339374-A2 COMPOSITIONS CONTAINING HETEROPOLYMERS AND METHODS OF USING SAME l'Oreal SA (FR) 2003-09-03 EP claimed
US-20030082126-A9 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same L'OREAL S.A. (FR) 2003-05-01 US claimed
US-20020122781-A1 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same PINZON CARLOS O (US) 2002-09-05 US claimed
WO-2002047620-A2 COMPOSITIONS CONTAINING HETEROPOLYMERS AND METHODS OF USING SAME L'OREAL SA (FR) 2002-06-20 WO claimed
WO-2002047658-A2 COSMETIC COMPOSITIONS CONTAINING HETEROPOLYMERS AND OIL-SOLUBLE CATIONIC SURFACTANTS AND METHODS OF USING SAME L'OREAL SA (FR) 2002-06-20 WO claimed
CN-1065126-C Hair styling conditioners PROCTER & GAMBLE (US) 2001-05-02 CN claimed
US-5120531-A Rinse-off hair conditioner containing polymer and nonaqueous s solvent THE PROCTER & GAMBLE COMPANY (US) 1992-06-09 US claimed
CN-1056053-A HAIR STYLING CONDITIONERS PROCTER & GAMBLE (US) 1991-11-13 CN claimed
US-12624313-B2 Suspending polymer composition, and method of use thereof ISP INVESTMENTS LLC (US) 2026-05-12 US disclosed
US-4077891-A Fabric treatment compositions THE PROCTER & GAMBLE COMPANY (US) 1978-03-07 US disclosed
US-3966853-A HEATING, DRYING, ANTI-CAKING AGENT MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) 1976-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020122781-A1 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same SYMPK, CUTA, LSS DNM1 1828/4885TSHR 2917/4885EPHX1 2204/4885
US-20030082126-A9 Cosmetic compositions containing heteropolymers and oil-soluble cationic surfactants and methods of using same SYMPK, CUTA, LSS DNM1 1828/4885TSHR 2917/4885EPHX1 2204/4885
US-12624313-B2 Suspending polymer composition, and method of use thereof MUC1, ALG1, CHD1 DNM1 3086/4885TSHR 4202/4885EPHX1 2969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.